Prana Biotechnology - Stock Price History | ATHE

Historical daily share price chart and data for Prana Biotechnology since 2021 adjusted for splits. The latest closing stock price for Prana Biotechnology as of September 27, 2021 is 1.31.
  • The all-time high Prana Biotechnology stock closing price was 73.97 on January 30, 2014.
  • The Prana Biotechnology 52-week high stock price is 3.58, which is 173.3% above the current share price.
  • The Prana Biotechnology 52-week low stock price is 1.09, which is 16.8% below the current share price.
  • The average Prana Biotechnology stock price for the last 52 weeks is 1.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Prana Biotechnology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 1.2474 0.7700 3.4300 0.3592 1.3400 71.79%
2019 1.3479 1.9200 2.1000 0.7800 0.7800 -39.06%
2018 2.1077 3.2500 3.2500 1.1299 1.2800 -58.97%
2017 2.6769 1.7500 3.6000 1.7500 3.1200 91.41%
2016 3.7183 4.2759 5.9800 1.6300 1.6300 -62.47%
2015 6.7100 10.0180 10.0180 4.2591 4.3431 -55.85%
2014 22.3610 42.1716 73.9652 8.8782 9.8380 -76.60%
2013 20.1167 13.7972 44.5111 12.5975 42.0516 218.64%
2012 11.0851 8.7582 17.7564 8.5783 13.1974 49.66%
2011 10.5427 7.7385 22.0756 7.4385 8.8182 17.60%
2010 8.0769 7.9184 14.4571 6.5987 7.4985 -5.30%
2009 9.6398 13.9178 17.2765 5.9988 7.9184 -30.53%
2008 22.1102 24.8350 33.5333 9.7780 11.3977 -52.50%
2007 17.0083 18.7762 23.9958 12.6575 23.9952 31.58%
2006 13.3867 9.5321 25.1350 8.2184 18.2364 94.87%
2005 12.7375 24.4751 28.0744 6.4187 9.3581 -61.58%
2004 27.3038 29.6341 52.6695 20.4559 24.3551 -17.98%
2003 26.8596 29.9340 32.9934 21.1758 29.6941 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.030B $0.003B
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29